Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Nuclear Medicine

Free Subscription Articles published in Brain Retrieve available abstracts of 54 articles: HTML format

Single Articles

February 2026
1. MIZUNO Y, Carreira Figueiredo I, Pillinger T, Hindley G, et al
   Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study.
   Brain. 2026;149:620-631.
   PubMed     Abstract available
   
   
   
2. CHIARO G, Vichayanrat E, Koay S, Rogeau A, et al
   Pure autonomic failure: a natural history study of the Queen Square cohort.
   Brain. 2026;149:606-619.
   PubMed     Abstract available
   
   
   January 2026
3. KALINOWSKI A, Steinman L
   The complexity of interpreting TSPO PET neuroimaging in first-episode psychosis.
   Brain. 2026 Jan 8:awaf476. doi: 10.1093.
   PubMed    
   
   
   December 2025
4. ZHU GH, He R, Yang ZY, Wang TT, et al
   Compensatory roles of STT3A and ALG5 in glucose metabolism of aged macaque hippocampus.
   Brain. 2025;148:4416-4434.
   PubMed     Abstract available
   
   
   
5. HVINGELBY VS, Terkelsen MH, Johnsen EL, Moller M, et al
   Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's disease.
   Brain. 2025;148:4508-4518.
   PubMed     Abstract available
   
   
   November 2025
6. KIM R, Jin B, Kim H, Woo KA, et al
   Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder.
   Brain. 2025;148:4084-4097.
   PubMed     Abstract available
   
   
   October 2025
7. ALBORNOZ EA, Mardon K, Bhalla R, Kumar V, et al
   PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models.
   Brain. 2025 Oct 16:awaf372. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2025
8. JOHNSON DR, Wiste HJ, Lowe V, Schwarz CG, et al
   Staging Alzheimer's disease through amyloid and tau PET.
   Brain. 2025 Sep 19:awaf346. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. PESCOLLER J, Dewenter A, Dehsarvi A, Steward A, et al
   Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's disease.
   Brain. 2025 Sep 12:awaf339. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
10. DE BRUIN H, Groot C, Barthel H, Bischof GN, et al
    Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.
    Brain. 2025 Aug 14:awaf279. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
11. ANAND C, Abdelnour F, Sipes B, Ma D, et al
    Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.
    Brain. 2025 Jul 9:awaf179. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. KAZAZIAN K, Monti MM, Owen AM
    Functional neuroimaging in disorders of consciousness: towards clinical implementation.
    Brain. 2025;148:2283-2298.
    PubMed     Abstract available
    
    
    
13. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Zhang L, Castro-Labrador S, et al
    The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients.
    Brain. 2025;148:2441-2452.
    PubMed     Abstract available
    
    
    
14. CICOGNOLA C, Salvado G, Smith R, Palmqvist S, et al
    APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.
    Brain. 2025;148:2373-2383.
    PubMed     Abstract available
    
    
    June 2025
15. PRANGE S, Metereau E, Klinger H, Huddlestone M, et al
    Serotonergic dysfunction in patients with impulse control disorders in Parkinson's disease.
    Brain. 2025;148:2108-2121.
    PubMed     Abstract available
    
    
    May 2025
16. KOCH PJ, Frey BM, Backhaus W, Petersen N, et al
    Neurotransmitter-informed connectivity maps and their application for outcome inference after stroke.
    Brain. 2025 May 20:awaf185. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. HONG H, Tozer DJ, Chen Y, Brown RB, et al
    Perivascular space dysfunction in cerebral small vessel disease is related to neuroinflammation.
    Brain. 2025;148:1540-1550.
    PubMed     Abstract available
    
    
    April 2025
18. LU K, Baker J, Nicholas JM, Street RE, et al
    Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults.
    Brain. 2025;148:1302-1315.
    PubMed     Abstract available
    
    
    February 2025
19. WIJESINGHE SS, Rowe JB, Mason HD, Allinson KSJ, et al
    Post-mortem validation of in vivo TSPO PET as a microglial biomarker.
    Brain. 2025 Feb 26:awaf078. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. EIFF B, Bullmore ET, Clatworthy MR, Fryer TD, et al
    Extra-axial inflammatory signal and its relationship to peripheral and central immunity in depression.
    Brain. 2025;148:635-646.
    PubMed     Abstract available
    
    
    
21. WARMENHOVEN N, Salvado G, Janelidze S, Mattsson-Carlgren N, et al
    A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests.
    Brain. 2025;148:416-431.
    PubMed     Abstract available
    
    
    
22. MALPETTI M, Swann P, Tsvetanov KA, Chouliaras L, et al
    Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration.
    Brain. 2025;148:493-505.
    PubMed     Abstract available
    
    
    January 2025
23. FERNANDEZ ARIAS J, Brum WS, Salvado G, Therriault J, et al
    Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum.
    Brain. 2025 Jan 29:awaf033. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. TOHYAMA S, Datko M, Brusaferri L, Kinder LD, et al
    Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine.
    Brain. 2025 Jan 28:awaf029. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. SAINBURG LE, Englot DJ, Morgan VL
    The impact of resective epilepsy surgery on the brain network: evidence from post-surgical imaging.
    Brain. 2025 Jan 24:awaf026. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. CHAUVEAU L, Landeau B, Dautricourt S, Turpin AL, et al
    Anterior-temporal network hyperconnectivity is key to Alzheimer's disease: from ageing to dementia.
    Brain. 2025 Jan 15:awaf008. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. WIMBERLEY C, Thompson G
    Bridging peripheral and central inflammation with TSPO-PET: insights into depression and beyond.
    Brain. 2025 Jan 9:awae403. doi: 10.1093.
    PubMed    
    
    
    November 2024
28. DUONG MT, Das SR, Khandelwal P, Lyu X, et al
    Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer and Lewy body disease.
    Brain. 2024 Nov 22:awae352. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. SAKATO Y, Shima A, Terada Y, Takeda K, et al
    Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease.
    Brain. 2024;147:3702-3713.
    PubMed     Abstract available
    
    
    
30. SPITZ G, Hicks AJ, McDonald SJ, Dore V, et al
    Plasma biomarkers in chronic single moderate-severe traumatic brain injury.
    Brain. 2024;147:3690-3701.
    PubMed     Abstract available
    
    
    October 2024
31. KATSUMI Y, Howe IA, Eckbo R, Wong B, et al
    Default mode network tau predicts future clinical decline in atypical early Alzheimer's disease.
    Brain. 2024 Oct 16:awae327. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. BANWINKLER M, Dzialas V, Rigoux L, Asendorf AL, et al
    Putaminal dopamine modulates movement motivation in Parkinson's disease.
    Brain. 2024;147:3352-3357.
    PubMed     Abstract available
    
    
    
33. D'ANGREMONT E, van der Zee S, Slingerland S, Slomp AC, et al
    Cholinergic deficiency in Parkinson's disease patients with visual hallucinations.
    Brain. 2024;147:3370-3378.
    PubMed     Abstract available
    
    
    September 2024
34. ABANTO J, Dwivedi AK, Imbimbo BP, Espay AJ, et al
    Increases in amyloid-beta42 slow cognitive and clinical decline in Alzheimer's disease trials.
    Brain. 2024 Sep 11:awae216. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
35. APPLETON J, Finn Q, Zanotti-Fregonara P, Yu M, et al
    Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.
    Brain. 2024 Jul 16:awae234. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. DEVULDER A, Vanderlinden G, Van Langenhoven L, Testelmans D, et al
    Epileptic activity on foramen ovale electrodes is associated with sleep and tau pathology in Alzheimer's disease.
    Brain. 2024 Jul 11:awae231. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. NILSSON J, Pichet Binette A, Palmqvist S, Brum WS, et al
    Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.
    Brain. 2024;147:2414-2427.
    PubMed     Abstract available
    
    
    June 2024
38. PERETTI DE, Boccalini C, Ribaldi F, Scheffler M, et al
    Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline.
    Brain. 2024 Jun 28:awae211. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. ROEMER SN, Brendel M, Gnoerich J, Malpetti M, et al
    Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.
    Brain. 2024 Jun 6:awae174. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
40. ALTMANN A, Aksman LM, Oxtoby NP, Young A, et al
    Towards cascading genetic risk in Alzheimer's disease.
    Brain. 2024 May 31:awae176. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. TETZLOFF KA, Martin PR, Duffy JR, Utianski RL, et al
    Longitudinal flortaucipir, metabolism and volume differ between phonetic and prosodic speech apraxia.
    Brain. 2024;147:1696-1709.
    PubMed     Abstract available
    
    
    
42. CROWLEY SJ, Kanel P, Roytman S, Bohnen NI, et al
    Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.
    Brain. 2024;147:1799-1808.
    PubMed     Abstract available
    
    
    April 2024
43. CODY KA, Langhough RE, Zammit MD, Clark L, et al
    Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Brain. 2024 Apr 26:awae116. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. WANG YT, Therriault J, Servaes S, Tissot C, et al
    Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
    Brain. 2024;147:1497-1510.
    PubMed     Abstract available
    
    
    March 2024
45. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
    Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
    Brain. 2024;147:936-948.
    PubMed     Abstract available
    
    
    February 2024
46. YANG HS, Yau WW, Carlyle BC, Trombetta BA, et al
    Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Brain. 2024 Feb 5:awae034. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
47. HERRANZ E, Treaba CA, Barletta VT, Mehndiratta A, et al
    Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
    Brain. 2024 Jan 30:awae030. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. BAGNATO F, Sati P, Hemond CC, Elliott C, et al
    Imaging chronic active lesions in multiple sclerosis: a consensus statement.
    Brain. 2024 Jan 16:awae013. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
49. SCHUMACHER J, Kanel P, Dyrba M, Storch A, et al
    Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
    Brain. 2023;146:4964-4973.
    PubMed     Abstract available
    
    
    November 2023
50. SILVA-RODRIGUEZ J, Labrador-Espinosa MA, Moscoso A, Scholl M, et al
    Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.
    Brain. 2023;146:4520-4531.
    PubMed     Abstract available
    
    
    October 2023
51. LAURENCIN C, Lancelot S, Brosse S, Merida I, et al
    Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
    Brain. 2023 Oct 3:awad338. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
52. BOCANCEA DI, Svenningsson AL, van Loenhoud AC, Groot C, et al
    Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Brain. 2023;146:3719-3734.
    PubMed     Abstract available
    
    
    
53. COOMANS EM, Tomassen J, Ossenkoppele R, Tijms BM, et al
    Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
    Brain. 2023;146:3735-3746.
    PubMed     Abstract available
    
    
    July 2023
54. AKSMAN LM, Oxtoby NP, Scelsi MA, Wijeratne PA, et al
    A data-driven study of Alzheimer's disease related amyloid and tau pathology progression.
    Brain. 2023 Jul 11:awad232. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum